1. Home
  2. GKOS vs SPXC Comparison

GKOS vs SPXC Comparison

Compare GKOS & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • SPXC
  • Stock Information
  • Founded
  • GKOS 1998
  • SPXC 1912
  • Country
  • GKOS United States
  • SPXC United States
  • Employees
  • GKOS N/A
  • SPXC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • SPXC Industrial Machinery/Components
  • Sector
  • GKOS Health Care
  • SPXC Industrials
  • Exchange
  • GKOS Nasdaq
  • SPXC Nasdaq
  • Market Cap
  • GKOS 7.4B
  • SPXC 7.3B
  • IPO Year
  • GKOS 2015
  • SPXC N/A
  • Fundamental
  • Price
  • GKOS $138.39
  • SPXC $163.11
  • Analyst Decision
  • GKOS Strong Buy
  • SPXC Hold
  • Analyst Count
  • GKOS 12
  • SPXC 2
  • Target Price
  • GKOS $135.08
  • SPXC $142.00
  • AVG Volume (30 Days)
  • GKOS 600.5K
  • SPXC 268.1K
  • Earning Date
  • GKOS 11-04-2024
  • SPXC 10-30-2024
  • Dividend Yield
  • GKOS N/A
  • SPXC N/A
  • EPS Growth
  • GKOS N/A
  • SPXC 449.97
  • EPS
  • GKOS N/A
  • SPXC 3.72
  • Revenue
  • GKOS $360,347,000.00
  • SPXC $1,919,600,000.00
  • Revenue This Year
  • GKOS $22.68
  • SPXC $16.18
  • Revenue Next Year
  • GKOS $24.98
  • SPXC $6.43
  • P/E Ratio
  • GKOS N/A
  • SPXC $43.35
  • Revenue Growth
  • GKOS 18.70
  • SPXC 12.84
  • 52 Week Low
  • GKOS $59.22
  • SPXC $83.98
  • 52 Week High
  • GKOS $145.84
  • SPXC $173.30
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 55.15
  • SPXC 52.53
  • Support Level
  • GKOS $124.60
  • SPXC $162.64
  • Resistance Level
  • GKOS $145.84
  • SPXC $170.28
  • Average True Range (ATR)
  • GKOS 5.15
  • SPXC 6.00
  • MACD
  • GKOS 0.30
  • SPXC 0.75
  • Stochastic Oscillator
  • GKOS 64.92
  • SPXC 73.16

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company generates majority of its revenue in the United States and rest from China, United Kingdom and other regions.

Share on Social Networks: